FARICIMAB

UNII:	QC4F7FKK7I
Formula:
Preferred Substance Name:	FARICIMAB
GSRS Full Record:	QC4F7FKK7I i

1607793-29-2
FARICIMAB [INN]
FARICIMAB [JAN]
FARICIMAB [USAN]
FARICIMAB [WHO-DD]
FARICIMAB SVOA [WHO-DD]
FARICIMAB-SVOA
IMMUNOGLOBULIN G1, ANTI-(HUMAN ANGIOPOIETIN 2) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A) (HUMAN-MUS MUSCULUS MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LIGHT CHAIN
RG7716
RG-7716
RG-7716 (ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR/ANTI-ANGIOPOIETIN 2 BISPECIFIC ANTIBODY)
RO6867461
RO-6867461
VABYSMO
Y8HA1I28D3

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

FARICIMAB

Synonyms and Mappings

Resources